Sexual Functioning in Cervical Cancer Survivors
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Primary Objectives:
- To assess the entire range of sexual functioning (desire, arousal, orgasmic capacity, dyspareunia, and sexual satisfaction) over the course of treatment and early follow-up in patients with local and locally advanced cervical cancer;
- To assess general cancer-related QOL over the course of treatment and early follow-up in patients with local and locally advanced cervical cancer;
- To characterize the relationship between sexual dysfunction and overall cancer-related QOL over time; and
- To identify factors that may predict better sexual function outcomes in patients treated for cervical cancer.
Secondary Objectives:
- Describe vaginal changes objectively via measurement of vaginal length.
- Demonstrate reliability of the vaginal length instrument and its applicability to future studies.
| Condition | Intervention |
|---|---|
|
Cervical Cancer |
Behavioral: Questionnaire |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Sexual Functioning and Quality of Life in Women With Cervical Cancer |
- To evaluate sexual functioning and the quality of life (QOL) in women with cervix cancer. [ Time Frame: 7 Years ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 165 |
| Study Start Date: | September 2002 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Questionnaire
Questionnaire
|
Behavioral: Questionnaire
Participants who are treated with radiation therapy: Questionnaires 5 times. Participants who undergo a radical hysterectomy: Questionnaires 4 times. Other Name: Survey
|
Detailed Description:
FIRST PART: NO LONGER RECRUITING
There are two parts to this study. The first part is called a "feasibility study" and will include 20 women who have been treated for cervix cancer in the past. These women will be asked to fill out questionnaires to evaluate their quality of life and sexual functioning. The questionnaires will only be completed once. The questionnaires will be filled out during routine clinic visits.
SECOND PART: RECRUITING
If the feasibility study is successful (if the majority of the 20 women are able to complete the questionnaires), the second part of the study will be performed with a larger number of women who have been diagnosed with cervix cancer but who have not yet begun treatment. Patients who participate in this part of the study will also be asked to fill out the questionnaires described above.
Participants who are treated with radiation therapy will be asked to complete questionnaires 5 times: before radiation treatment starts, at the time of the first ALTO, and 1 month, 4 months and 7 months after treatment ends. Vaginal measurements will only be done 4 times: at the time of first ALTO, and 1 month, 4 months and 7 months after treatment ends.
Participants who undergo a radical hysterectomy will be asked to complete questionnaires and have a vaginal measurement 4 times: before surgery and 1 month, 4 months and 7 months after treatment ends. Vaginal measurements will only be done 4 times: at the time of first ALTO, and 1 month, 4 months and 7 months after treatment ends.
The questionnaires take about 20 minutes to complete. The vaginal measurement is done by a doctor and takes less than a minute to complete.
This is an investigational study. About 165 patients will take part in this multicenter study. About 135 patients will be enrolled at M. D. Anderson.
Eligibility| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Women with history of cervical cancer.
Inclusion Criteria:
Eligibility criteria for 20 women in the pilot study (see Treatment Plan for details) of feasibility include:
- History of cervical cancer (within 3 months to 5 years of diagnosis)
- English or Spanish-speaking
- Ability to give informed consent
Eligibility criteria for the main study:
- New diagnosis of local or locally advanced cervical cancer
- English or Spanish-speaking
- Ability to give informed consent
Exclusion Criteria:
- Patients who are illiterate
- Patients who have undergone an exenteration
- Patients who do not speak English or Spanish
Contacts and Locations| United States, Texas | |
| UT MD Anderson Cancer Center | |
| Houston, Texas, United States, 77030 | |
| Principal Investigator: | Diane C. Bodurka, MD | M.D. Anderson Cancer Center |
More Information
Additional Information:
No publications provided
| Responsible Party: | M.D. Anderson Cancer Center |
| ClinicalTrials.gov Identifier: | NCT00522223 History of Changes |
| Other Study ID Numbers: | ID02-376 |
| Study First Received: | August 28, 2007 |
| Last Updated: | September 26, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by M.D. Anderson Cancer Center:
|
Cervical Cancer Cancer Survivors Cervix Cancer Sexual Functioning |
Quality Of Life Questionnaire Radiation Therapy Radical Hysterectomy |
Additional relevant MeSH terms:
|
Uterine Cervical Neoplasms Uterine Neoplasms Genital Neoplasms, Female Urogenital Neoplasms Neoplasms by Site |
Neoplasms Uterine Cervical Diseases Uterine Diseases Genital Diseases, Female |
ClinicalTrials.gov processed this record on June 17, 2013